Shortlist by what you need
Start here if you know why you are leaving DrugCard.
Want the closest match?
NarrativaMost similar to DrugCard in what it does, its category and its price.
Visit (opens Narrativa in a new tab)Want the best rated?
Unlearn.AIRated 4.2 out of 5 in our review, against 4.2 for DrugCard.
Visit (opens Unlearn.AI in a new tab)
At a glance
Green means better than DrugCard, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
 DrugCardBaseline | 4.2 | Not listed | No | AI-powered literature-screening platform that automates pharmacovigilance and adverse-event monitoring across languages. | |
| Narrativa | 3.6−0.6 | Not listed | No | Agentic AI generates compliant clinical study reports, patient narratives, and regulatory submissions at scale - GxP-ready, GDPR-aligned, and built to an FDA/EMA-aligned safety framework. | vs DrugCard |
 Immunai | 4.0−0.2 | Not listed | No | AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners. | vs DrugCard |
| Unlearn.AI | 4.2Same | Not listed | No | Digital twins of trial participants that shrink the control arm by about a third. | vs DrugCard |
 Aizon | 4.0−0.2 | Not listed | No | An AI platform for pharmaceutical manufacturers that catches quality deviations in GxP-regulated production data. | vs DrugCard |
The alternatives in detail
In order of how closely each one matches DrugCard.
Narrativa
3.6Not listed
vs DrugCard−0.6
Agentic AI generates compliant clinical study reports, patient narratives, and regulatory submissions at scale - GxP-ready, GDPR-aligned, and built to an FDA/EMA-aligned safety framework.
- Agentic AI generates clinical study reports and patient narratives
- Knowledge graph technology for complex clinical relationships
- GxP-ready validation architecture
Purpose-built compliance architecture (GxP/FDA/EMA-aligned), not generic enterprise AI
No published pricing - an enterprise sales process
Immunai
4.0Not listed
vs DrugCard−0.2
AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners.
- AMICA-OS platform built on single-cell multi-omic immune system data
- Target discovery tools for identifying new drug candidates from immune cell behavior
- Preclinical evaluation modeling for testing target hypotheses before trials
Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate
No published pricing; every engagement is a custom partnership negotiation
Unlearn.AI
4.2Not listed
vs DrugCardSame
Digital twins of trial participants that shrink the control arm by about a third.
- Digital twins forecasting participant outcomes
- Control arm size reduction of around 33 percent
- Scout for literature and regulatory search
Fewer control participants is an ethical gain as well as a commercial one
No published pricing
Aizon
4.0Not listed
vs DrugCard−0.2
An AI platform for pharmaceutical manufacturers that catches quality deviations in GxP-regulated production data.
- Real-time deviation detection across GxP manufacturing data
- Audit-ready documentation generated automatically from production data
- Aizon Predict available as an AWS Marketplace private offer
Deep specialization in GxP compliance sets it apart from general manufacturing-analytics tools
Pricing is entirely custom and not disclosed anywhere publicly
FAQ
Questions people ask
Is DrugCard free?
DrugCard does not list a free plan. Check its pricing page for current plans.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.